American Fusion Expands Scientific Team and IP Portfolio as Texatron Testing Advances

American Fusion Inc. appoints a strategic advisor and files six additional patent applications, bolstering its fusion energy platform as it moves into advanced testing phases.

NY Metrowire Staff
Technology
American Fusion Expands Scientific Team and IP Portfolio as Texatron Testing Advances

American Fusion Inc. (OTC: AMFN), a developer of next-generation fusion energy technologies, is strengthening its scientific and intellectual property foundation as it accelerates testing of its Texatron Fusion Engine. The company announced the appointment of Dr. Noah D’Amico, a physicist and engineer at Texas Tech University, as a Strategic Advisor, and the filing of six additional U.S. patent applications, bringing its total to 82.

Dr. D’Amico, who continues his work at Texas Tech and BlankSlate Innovation, brings expertise in nuclear diagnostics, neutron detection, radiation measurement, vacuum-system design, and AI-based analysis of CR-39 nuclear particle tracks. His Ph.D. in Physics from Texas Tech, earned in 2026, focused on advanced diagnostic techniques relevant to fusion research. The appointment is expected to enhance the company’s capabilities in diagnostics and engineering as it prepares further Texatron evaluations at Texas Tech.

American Fusion has begun testing its Texatron platform at Texas Tech after completing initial laboratory preparations and verifying its remote ignition system. The next testing phase will examine subsystems including plasma and magnetic-field control, ignition, fuel delivery, and electronic components. These tests are critical to validating the technology’s potential for commercial fusion energy.

The expansion of the scientific team and patent portfolio underscores American Fusion’s commitment to advancing its fusion energy technology. With 82 U.S. patent applications, the company is building a robust IP moat around its innovations. The new patents likely cover various aspects of the Texatron system, including plasma confinement, fuel injection, and diagnostic methods.

The appointment of Dr. D’Amico and the additional filings come at a pivotal time for the fusion industry, which has seen increased investment and interest from governments and private entities. Fusion energy promises a nearly limitless, clean power source, and American Fusion aims to be at the forefront of this emerging sector.

Investors and industry observers are watching American Fusion’s progress closely. The company’s ability to attract top scientific talent and expand its IP portfolio suggests it is serious about overcoming the technical challenges of fusion. The upcoming tests at Texas Tech will be a key milestone, providing data on the performance of the Texatron platform.

For more information on American Fusion, visit the company’s newsroom at https://nnw.fm/AMFN.

Blockchain Registration

QR Code for Blockchain Registration